View by Specialty

Trending

Anthony A. Romeo
November 15, 2024
4 min read
Save

Capitalism is the path to value-based care

Lupus News

SPONSORED CONTENT
Save
SPONSORED CONTENT
September 29, 2019
2 min read
Save

Dermatology pearls: Encourage sun protection, optimize steroids for cutaneous lupus

Dermatology pearls: Encourage sun protection, optimize steroids for cutaneous lupus

SAN DIEGO — While encouraging patients with cutaneous lupus erythematosus to use adequate sun protection, rheumatologists should be treating disease flares with more potent steroids then tapering off once other therapies are in progress, according to a presentation at the 2019 Congress of Clinical Rheumatology West.

SPONSORED CONTENT
September 28, 2019
2 min read
Save

Reconsidering, retiring the controversial ‘lupus headache’

Reconsidering, retiring the controversial ‘lupus headache’

SAN DIEGO — Although “lupus headache” remains a disease-related entity in the Systemic Lupus Erythematosus Disease Activity Index, debate persists over the lack of a detailed definition for this type of headache and whether it represents a neuropsychiatric symptom of lupus, according to a presentation at the 2019 Congress of Clinical Rheumatology West.

Trending

Anthony A. Romeo
November 15, 2024
4 min read
Save

Capitalism is the path to value-based care

SPONSORED CONTENT
September 28, 2019
2 min read
Save

Minimizing prednisone, nephrotoxic agents crucial for lupus nephritis outcomes

Minimizing prednisone, nephrotoxic agents crucial for lupus nephritis outcomes

SAN DIEGO — Rheumatologists treating patients with lupus nephritis should make a concerted effort to reduce or avoid use of NSAIDs and other nephrotoxic drugs in order to improve long-term outcomes, according to a presentation at the 2019 Congress of Clinical Rheumatology West.

SPONSORED CONTENT
September 27, 2019
2 min read
Save

Rheumatologist input absent in disputed hydroxychloroquine guidelines

Rheumatologist input absent in disputed hydroxychloroquine guidelines

SAN DIEGO — The 2016 recommendations by the American Academy of Ophthalmology on “proper” dosage of hydroxychloroquine lacked essential input from rheumatologists who rely on the drug to improve survival in patients with systemic lupus erythematosus, according to a presentation at the 2019 Congress of Clinical Rheumatology West.

SPONSORED CONTENT
September 20, 2019
13 min read
Save

When Autoimmune Disease Strikes Thrice: Managing Multiple Autoimmune Syndrome

When Autoimmune Disease Strikes Thrice: Managing Multiple Autoimmune Syndrome

By the time Lilly Stairs was diagnosed with psoriatic arthritis at the age of 19 — following an arduous series of tests and doctor visits — she had already been living with an autoimmune disease for 12 years.

SPONSORED CONTENT
September 18, 2019
3 min read
Save

Gazyva receives FDA breakthrough therapy designation for lupus nephritis

Gazyva receives FDA breakthrough therapy designation for lupus nephritis

The FDA has granted Gazyva breakthrough therapy designation for the treatment of adult patients with lupus nephritis, according to a Genentech press release.

SPONSORED CONTENT
September 17, 2019
2 min read
Save

Infusion reactions to rituximab more significant in SLE than other diseases

Infusion reactions to rituximab more significant in SLE than other diseases

Infusion reaction rates to rituximab may be more significant among patients with systemic lupus erythematosus than other diseases, according to findings published in BMC Rheumatology.

SPONSORED CONTENT
September 12, 2019
2 min read
Save

Stress ‘primary driver’ for fatigue in patients with SLE

Stress ‘primary driver’ for fatigue in patients with SLE

Although depression and stress are both predictors of fatigue among patients with systemic lupus erythematosus at 1 year, stress is the “primary driver,” and reductions in stress are associated with a clinically meaningful decrease in fatigue, according to findings published in Arthritis Care & Research.

SPONSORED CONTENT
August 29, 2019
2 min read
Save

Hypertension, preeclampsia mediate adverse pregnancy outcomes in RA, SLE, psoriasis

Hypertension, preeclampsia mediate adverse pregnancy outcomes in RA, SLE, psoriasis

Among patients with rheumatoid arthritis, systemic lupus erythematosus and psoriasis, the presence of hypertension or preeclampsia accounts for approximately 10% to 33% of the excess risk for preterm birth, caesarean delivery and small for gestational age, according to data published in Arthritis Care & Research.

SPONSORED CONTENT
August 22, 2019
5 min watch
Save

APOL1 variant gene may explain lupus outcome disparities between black, white patients

APOL1 variant gene may explain lupus outcome disparities between black, white patients

HILTON HEAD, S.C. — A variant of the apolipoprotein L gene could help explain why patients of African ancestry with lupus typically experience worse disease-related outcomes compared with white patients, according to Ashira Blazer, MD, a rheumatologist and assistant professor at the NYU School of Medicine.

View more